These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

181 related items for PubMed ID: 5987377

  • 1. [2 years of exclusive use of diallyl-nor-toxiferine as relaxant in clinical anesthesia].
    Chott F.
    Anaesthesist; 1966 Mar; 15(3):81-3. PubMed ID: 5987377
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. [Diallyl-nor-toxiferine in anesthesia with ethyl ether].
    Bainy RJ.
    Rev Bras Anestesiol; 1971 Mar; 21(1):36-41. PubMed ID: 5096262
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. All-nor-toxiferin report on two hundred cases.
    Garwacki J.
    West Afr Med J; 1966 Aug; 15(4):149-51. PubMed ID: 5916290
    [No Abstract] [Full Text] [Related]

  • 8. [Research on ocular hypotonia caused by alloferine during general anesthesia].
    Tota G, Vagelli A, Busoni P.
    Ann Ottalmol Clin Ocul; 1967 Feb; 93(2):171-9. PubMed ID: 5601344
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [Diallyl-nor-toxiferine as a curarizing agent in renal failure patients].
    Nizard D, Debras G, Vigreux G, Poisvert M.
    Cah Anesthesiol; 1972 Nov; 20(7):775-83. PubMed ID: 4660729
    [No Abstract] [Full Text] [Related]

  • 11. [Our experience on the use of the new muscle relaxant diallyl-2-nortoxiferine, Alloferin].
    García Perla JL.
    Rev Esp Anestesiol Reanim; 1971 Jan; 18(1):93-6. PubMed ID: 5552985
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. The influence of carbon dioxide on the neuromuscular blocking properties of tubocurarine chloride and diallyl-nor-toxiferine dichloride (Alloferin Roche) in man. A comparative study.
    Coleman AJ, Ripley SH, Sliom CM, Knowles SL.
    Bull Schweiz Akad Med Wiss; 1967 Aug; 23(1):98-105. PubMed ID: 4860569
    [No Abstract] [Full Text] [Related]

  • 14. Clinical experiences with diallyl-nor-toxiferine and the curare antidote galanthamine.
    Mayrhofer O.
    South Med J; 1966 Nov; 59(11):1364-8. PubMed ID: 5333582
    [No Abstract] [Full Text] [Related]

  • 15. An introduction to diallyl-nor-toxiferene, a blocking muscle relaxant.
    Cole WH.
    Med J Aust; 1966 Aug 06; 2(6):268-70. PubMed ID: 5946870
    [No Abstract] [Full Text] [Related]

  • 16. [Clinical trials with a toxiferine derivative].
    Torres PR, Blanc V.
    Rev Esp Anestesiol; 1966 Jan 06; 13(1):24-6. PubMed ID: 5989611
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. The choice and mode of administration of relaxants.
    Foldes FF.
    Clin Anesth; 1966 Jan 06; 2():1-32. PubMed ID: 5958093
    [No Abstract] [Full Text] [Related]

  • 19. [Clinical evaluation of diallyl-bis-nor-toxiferine chloride].
    de Freitas PE, Dória Rda S, Carvalho RM, de Araújo EL, de Carvalho RV.
    Rev Bras Anestesiol; 1966 Jan 06; 16(4):451-7. PubMed ID: 5998426
    [No Abstract] [Full Text] [Related]

  • 20. [Combined use in neuroleptanalgesia of diazepam and diallyl-nor-toxiferine].
    Richter K.
    Anesth Analg (Paris); 1966 Jan 06; 23(2):371-9. PubMed ID: 5933545
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.